Cite
Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis
MLA
Manuel J, Koppe, et al. “Radioimmunotherapy Is an Effective Adjuvant Treatment after Cytoreductive Surgery of Experimental Colonic Peritoneal Carcinomatosis.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 47, no. 11, Nov. 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8770c4207b9404ef93a2158fb19f3cc3&authtype=sso&custid=ns315887.
APA
Manuel J, K., Thijs, H., Otto C, B., Wim J G, O., & Robert P, B. (2006). Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 47(11).
Chicago
Manuel J, Koppe, Hendriks Thijs, Boerman Otto C, Oyen Wim J G, and Bleichrodt Robert P. 2006. “Radioimmunotherapy Is an Effective Adjuvant Treatment after Cytoreductive Surgery of Experimental Colonic Peritoneal Carcinomatosis.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 47 (11). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........8770c4207b9404ef93a2158fb19f3cc3&authtype=sso&custid=ns315887.